DOI QR코드

DOI QR Code

In-vitro Tests of Topical Skin Protectants using a Flow-Through Diffusion Cell System Containing Excised Hairless Mouse Skin

생체 피부조직을 이용한 피부보호제 in-vitro 시험평가

  • Lee, Eun Young (Drug Delivery Research Team, Cellgentek Co, LTD.) ;
  • Choi, Hoo Kyun (Drug Delivery Research Team, Cellgentek Co, LTD.) ;
  • Kim, Sang Woong (Research and Development Center, Hanso Inc.) ;
  • Seo, Dong Sung (Research and Development Center, Hanso Inc.) ;
  • Joe, Hae Eun (Chem-Bio Technology Center, Agency for Defense Development) ;
  • Yu, Chi Ho (Chem-Bio Technology Center, Agency for Defense Development) ;
  • Kim, Chang Hwan (Chem-Bio Technology Center, Agency for Defense Development) ;
  • Cho, Young (Research and Development Center, Hanso Inc.)
  • 이은영 ((주)셀젠텍 약물전달기술연구팀) ;
  • 최후균 ((주)셀젠텍 약물전달기술연구팀) ;
  • 김상웅 (한소주식회사 부설연구소) ;
  • 서동성 (한소주식회사 부설연구소) ;
  • 조혜은 (국방과학연구소 Chem-Bio기술센터) ;
  • 유치호 (국방과학연구소 Chem-Bio기술센터) ;
  • 김창환 (국방과학연구소 Chem-Bio기술센터) ;
  • 조영 (한소주식회사 부설연구소)
  • Received : 2022.03.08
  • Accepted : 2022.07.22
  • Published : 2022.08.05

Abstract

Highly toxic chemical warfare agents(CWA) could be used in chemical warfare and terrorism. The protection of skin is crucial for civilians and soldiers, because the primary routes of exposure to CWA are inhalation and skin absorption. Thus, topical skin protectants(TSP) have been studied and developed in many countries to complement protective equipments. In this study, in-vitro test procedure was optimized and established using a flow-through diffusion cell system containing excised hairless mouse skin in an attempt to assess the effectiveness of various TSP formulations against nerve agent simulants. In addition, the test results on the formulations including the ingredients used in SERPACWA(Skin Exposure Reduction Paste Against Chemical Warfare Agent) and IB-1(TSP of Israel) were included, indicating that the formulations with perfluorinated compounds were more effective than the glycerin-based formulations.

Keywords

Acknowledgement

본 연구는 국방과학연구소의 연구비(과제명: rTSP제재 피부 보호 및 제독제 개발) 지원을 받아 수행되었으며 기술적으로 도와주신 국방과학연구소 Chem-Bio 기술센터에 감사 드립니다.

References

  1. Frederick R., "Textbook of Military Medicine," Published by the Office of Surgeon General Department of Army, USA, p. 141, 1997.
  2. J. Millerioux, et al., "Evaluation of In Vitro Tests to Assess the Efficacy of Formulations as Topical Skin Protectants against Organophosphorus Compounds," Toxicol. in Vitr., Vol. 23, pp. 127-133, 2009. https://doi.org/10.1016/j.tiv.2008.09.014
  3. J. Millerioux, et al., "In Vitro Selection and Efficacy of Topical Skin Protectants against the Nerve Agent VX," Toxicol. in Vitr., Vol. 23, pp. 539-545, 2009. https://doi.org/10.1016/j.tiv.2009.01.008
  4. Bignon C., et al., "Barrier Cream Based on CeO2 Nanoparticles Grafted Polymer as an Active Compound against the Penetration of Organophosphates," Chemico-Biological Inter., Vol. 267, pp. 17-24, 2017. https://doi.org/10.1016/j.cbi.2016.03.002
  5. Ernest H. Braue, Jr. "Development of an Active Topical Skin Protectant," USAMRICD-TR-16-03, pp. 1-180, Feb. 2016.
  6. Sandra L. Fox, et al., "Emergency First Responders' Experience with Colorimetric Detection Methods," Idaho National Laboratory U.S. Department of Homeland Security Under DOE Idaho Operations Office Contract DE-AC07-05ID14517, pp. 1-33, 2007. 10.
  7. Kim S. W., et al., "Study on the Formulations for Topical Skin Protectant against Liquid-Phase Chemical Warfare Agents," Journal of the Korea Institute of Military Science and Technology, Vol. 25, No. 2, pp. 210-217, 2022. https://doi.org/10.9766/KIMST.2022.25.2.210
  8. Carl T. Olson, et al., "Evaluation of Compounds as Barriers to Dermal Penetration of Organophosphates using Acetylcholinesterase Inhibition," Toxicol. Lett., Vol. 55, pp. 325-334, 1991. https://doi.org/10.1016/0378-4274(91)90014-W
  9. William G. Reifenra, et al., "A Comparison of in Vitro Skin-Penetration Cells," J. Pharm. Sci., Vol. 83, No. 9, pp. 1229-1233, Sep., 1994. https://doi.org/10.1002/jps.2600830908
  10. OECD Guideline for the Testing of Chemicals, "Skin Absorption: In Vitro Method," OECD/OCDE 428 Adopted : 13 April 2004.
  11. Akhter S., et al., "Automated Diffusion Apparatus for Studying Skin Penetration," Int. J. Pharm., Vol. 21, pp. 17-26, 1984. https://doi.org/10.1016/0378-5173(84)90199-6
  12. Bronaugh R., et al., "Methods for In Vitro Percutaneous Absorption Studies," J. Pharm. Sci., Vol. 74, pp. 64-67, 1985. https://doi.org/10.1002/jps.2600740117
  13. Addicks W., et al., "Validation of a Flow-Through Diffusion Cell for use in Transdermal Research," Pharm. Res., Vol. 4, pp 337-341, 1987. https://doi.org/10.1023/A:1016405506028
  14. Davies J., et al., "Further Development of an In Vitro Model for Studying the Penetration of Chemicals Through Compromised Skin," Toxicol. in Vitr., Vol. 38, pp. 101-107, 2017. https://doi.org/10.1016/j.tiv.2016.10.004
  15. Hoo-Kyun Choi, et al., "Mathematical Analysis and Optimization of a Flow-Through Diffusion Cell System," Pharm. Res., Vol. 11, No. 4, pp. 595-599, 1994. https://doi.org/10.1023/A:1018991221647
  16. Dalton H., et al., "Absorption of the Nerve Agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) Through Pig, Human and Guinea Pig Skin In Vitro," Toxicol. in Vitr., Vol. 20, pp. 1532-1536, 2006. https://doi.org/10.1016/j.tiv.2006.06.009
  17. Simon, G. A., et al., "The Pig as an Experimental Animal Model of Percutaneous Permeation in Man," Skin Pharmacol. Appl. Skin Physiol., Vol. 13, pp. 229-234, 2000. https://doi.org/10.1159/000029928
  18. Atchinson, C. R., et al., "Development of a Guinea Pig Model for Low Dose, Long Term Exposure to Organophosphorous Nerve Agent," Toxicol. Mech. Meth., Vol. 14, pp. 183-194, 2004. https://doi.org/10.1080/15376520490429166
  19. Wetherell, J., et al., "Physostigmine and Hyoscine Improves Protection against the Lethal and Incapacitating Effects of Nerve Agent Poisoning in the Guinea Pig," Neurotoxicol., Vol. 23, pp. 341- 349, 2002. https://doi.org/10.1016/S0161-813X(02)00082-7
  20. Addicks, W. J., et al., "Validation of a FlowThrough Diffusion Cell for use in Transdermal Research," Pharm. Res., Vol. 4, pp. 337-341, 1987. https://doi.org/10.1023/A:1016405506028
  21. Simon G. A., et al., "Comparative Evaluation of Rivastigmine Permeation from a Transdermal System in the Franz Cell using Synthetic Membranes and Pig Ear Skin with in Vivo-In Vitro Correlation," Inter. J. Pharm., Vol. 512, pp. 234-241, 2016. https://doi.org/10.1016/j.ijpharm.2016.08.052
  22. FDA. (1997). Guidance for Industry: SUPAC-SS Nonsterile Semisolid Dosage Forms: Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Release Testing and In Vivo Bioequivalence Documentation.
  23. Lalain T., et al., "Chemical Warfare Agents Decontamination Efficiency Testing Large-Scale Chamber mVHP Decontamination Evaluation," ECBC-TR-731, Edgewood Chemical and Biological Center, 2010.
  24. Lakshmi K., et al., "ZnO/PAN Nanofiber Catalyst for Photodegradation of Methyl Paraoxon and Its Toxicological Evaluation Utilizing Early Life Stages of Zebra Fish," Chem. Eng. J., Vol. 357, pp. 724-736, 2019. https://doi.org/10.1016/j.cej.2018.09.201
  25. SHANNON L., et al., "Review of Chemical Warfare Agent Simulants for the Study of Environmental Behavior," Critical Rev. in Environ. Sci. and Tech., Vol. 38, pp. 112-136, 2008. https://doi.org/10.1080/10643380701643650
  26. Song L., et al., "Photothermal Graphene Fabrics for Ultra Fast Catalytic Degradation of Chemical Warfare Agent Simulants," J. Hazard. Mater., Vol. 393, pp. 122-132, 2020.
  27. C. A. Moore, et al., "Use of a Human Skin In Vitro Model to Investigate the Influence of 'EveryDay' Clothing and Skin Surface Decontamination on the Percutaneous Penetration of Organophosphates," Toxicol. Lett., Vol. 229, pp. 257-264, 2014. https://doi.org/10.1016/j.toxlet.2014.06.007
  28. C. A. Moore, et al., "Percutaneous Absorption and Distribution of Organophosphates (Chlorpyrifos and Dichlorvos) Following Dermal Exposure and Decontamination Scenarios using In Vitro Human Skin Model," Toxicol. Lett., Vol. 229, pp. 66-72, 2014. https://doi.org/10.1016/j.toxlet.2014.06.008
  29. Dachir S., et al., "Dermostyx (IB1)-High Efficacy and Safe Topical Skin Protectant against Percutaneous Toxic Agents," Chemico-Biological, Inter., Vol. 267, pp. 25-32, 2017. https://doi.org/10.1016/j.cbi.2016.07.010
  30. Kadar T., et al., "A Topical Skin Protectant against Chemical Warfare Agents," Israel Med. Ass. J., Vol. 5, pp. 717-719, Oct. 2003.
  31. Ophir N., et al., "Using the Skin Protective Lotion IB1 as a Substitute for Chemical Protective Gloves," Am. J. Emer. Med., Vol. 34, pp. 1986-1990, 2016. https://doi.org/10.1016/j.ajem.2016.07.008